Antibiotic-resistant infection with Mycobacterium abscessus bacteria in people with cystic fibrosis…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Eloxx Pharmaceuticals has announced that it’s now added the approved cystic fibrosis…
A soft skin sticker that can rapidly measure chloride levels in sweat, which are elevated in…
Eloxx Pharmaceuticals has acquired Zikani Therapeutics and will expand its…
A precise gene-editing tool that reverses single DNA mutations may lead to genetic therapies for people with…
Molecular analysis of single cells lining the digestive tract found high CFTR activity — the gene associated with…
Endoscopic sinus surgery led to better lung function in people with moderate or severe cystic fibrosis (CF) — and some with mild disease — with benefits sustained one year after surgery, a medical records review found.
For the first time, bacteriophage therapy treated a boy with chronic and antibiotic-resistant Achromobacter…
The Achromobacter bacteria species that is an increasing source of chronic lung infections in people with…
Elevated levels of fecal calprotectin protein, a biomarker for intestinal inflammation, was linked to worse gastrointestinal symptoms and…